When you strain a tendon or overwork a muscle, your body runs a repair sequence: inflammation, new blood vessels, rebuilt tissue. So-called healing peptides like BPC-157 and TB-500 are studied for how they interact with that sequence.

Most of the research so far is preclinical — worth understanding before forming expectations — and these articles are honest about that line. They cover the mechanisms, the evidence, and the practical questions people ask, with every compound available only by prescription after a provider review.

43 articles on this topic

  1. Two people sharing a breakfast bowl of yogurt, eggs, and berries at a sunlit table

    KPV Peptide and the Gut Inflammation Evidence

    KPV is the C-terminal tripeptide of alpha-MSH, and in mice whose MC1R does not function, every animal in the KPV-treated group survived DSS colitis — a result that points away from melanocortin receptors entirely.

    August 13, 2026 · Julian Reyes, Health Writer

  2. A person in a cream hooded sweatshirt walking a quiet tree-lined path on an early morning walk

    TB-500 for Injury Recovery, Tissue by Tissue

    TB-500 is a synthetic fragment of thymosin beta-4. Human studies of the full-length parent also include intravenous Phase 1 safety and pharmacokinetic trials and topical ophthalmic trials, in addition to Phase 2 chronic-wound studies.

    August 13, 2026 · Julian Reyes, Health Writer

  3. A man resting on a wooden bench in warm light, water bottle at his side

    Wolverine Peptide Stack: Two Peptides, One Rx

    BPC-157 and TB-500 are usually sold together as the Wolverine peptide stack. This is what the published research measured, what it did not, and how a prescription evaluation works.

    August 5, 2026 · Julian Reyes, Health Writer

Page 3 of 3 · 43 articles